TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5584.65M
Enterprise Value 3441.43M
Trailing P/E N/A
Forward P/E 1-4.84
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3,836.75
Price/Book (mrq)6.76
Enterprise Value/Revenue 32,896.86
Enterprise Value/EBITDA 6-3.95

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-73,306.44%

Management Effectiveness

Return on Assets (ttm)-78.68%
Return on Equity (ttm)-163.30%

Income Statement

Revenue (ttm)152.38k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)152.38k
EBITDA -111.62M
Net Income Avi to Common (ttm)-111.29M
Diluted EPS (ttm)-1.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)91.84M
Total Cash Per Share (mrq)1.41
Total Debt (mrq)182.16k
Total Debt/Equity (mrq)0.23
Current Ratio (mrq)4.93
Book Value Per Share (mrq)1.22

Cash Flow Statement

Operating Cash Flow (ttm)-88.93M
Levered Free Cash Flow (ttm)-48.3M

Trading Information

Stock Price History

Beta 2.25
52-Week Change 365.66%
S&P500 52-Week Change 318.18%
52 Week High 315.35
52 Week Low 34.10
50-Day Moving Average 38.05
200-Day Moving Average 310.46

Share Statistics

Avg Vol (3 month) 31.28M
Avg Vol (10 day) 31.13M
Shares Outstanding 570.65M
Float 42.4M
% Held by Insiders 119.92%
% Held by Institutions 157.77%
Shares Short 317.89M
Short Ratio 310.92
Short % of Float 337.23%
Shares Short (prior month) 317.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/5625
Last Split Date 3Apr 30, 2012